ATAK · Aurora Technology Acquisition Corp. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | $19.01M | $18.16M | $13.04M | - | - | - | - | - | - |
| Cost of Revenue | - | $8.61M | $8.61M | $7.52M | - | - | - | - | - | - |
| Gross Profit | - | $10.40M | $9.56M | $5.40M | - | - | - | - | - | - |
| R&D | - | $1.66M | $1.91M | $1.64M | - | - | - | - | - | - |
| SG&A | - | $8.20M | $5.76M | $5.84M | - | - | - | - | - | - |
| Total Operating Expenses | - | $7.10M | $7.96M | $10.32M | - | - | - | - | - | ($1.37M) |
| D&A | - | $78.0K | $79.0K | $79.0K | - | - | - | - | - | - |
| Operating Income | - | ($2.75M) | $1.89M | ($1.65M) | - | ($479.3K) | ($837.6K) | ($1.55M) | - | ($219.3K) |
| Interest Expense | - | $185.0K | $26.0K | $120.0K | - | - | - | - | - | - |
| Income Tax | - | $367.0K | $52.0K | $723.0K | - | - | - | - | - | - |
| Net Income | - | ($3.73M) | ($234.0K) | ($614.0K) | - | $522.1K | $150.8K | ($361.4K) | - | $1.15M |
| EPS - Basic | - | $0.12 | ($0.01) | ($0.12) | - | - | - | - | - | $0.05 |
| EPS - Diluted | - | $0.12 | ($0.10) | ($0.02) | - | - | - | - | - | $0.05 |
Balance Sheet
| Line item | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.94M | $1.12M | $1.76M | $2.75M | $12.4K | $28.9K | $6.2K | $3.17M | $191.1K | $257.1K |
| Accounts Receivable | $3.25M | $3.83M | $6.38M | $5.69M | - | - | - | $6.00M | - | - |
| Inventory | $7.05M | $7.96M | $9.59M | $9.01M | - | - | - | $4.85M | - | - |
| Accounts Payable | $3.36M | $3.94M | $5.23M | $5.37M | $2.35M | $1.98M | $434.5K | $30.1K | - | - |
| Current Assets | $21.16M | $24.16M | $29.77M | $29.38M | $12.4K | $55.1K | $90.8K | $264.4K | $475.7K | $689.2K |
| Total Assets | $26.75M | $31.81M | $38.19M | $38.21M | $58.66M | $57.54M | $60.29M | $59.36M | $207.36M | $205.87M |
| Current Liabilities | $42.86M | $47.32M | $49.36M | $48.24M | $4.62M | $3.65M | $3.12M | $2.05M | $437.2K | $155.7K |
| Long-term Debt | $2.36M | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $63.89M | $69.70M | $72.59M | $72.20M | $11.96M | $11.16M | $10.56M | $9.79M | $8.10M | $7.76M |
| Stockholders' Equity | ($37.13M) | ($37.88M) | ($34.40M) | ($33.99M) | ($11.95M) | ($11.11M) | ($10.47M) | ($9.52M) | ($7.62M) | $15.1K |
| Retained Earnings | ($43.89M) | ($39.48M) | ($35.76M) | ($35.83M) | ($11.95M) | ($11.11M) | ($10.47M) | ($9.52M) | ($7.62M) | ($7.07M) |
Cash Flow
| Line item | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | ($475.0K) | - | - | - | ($136.3K) | - | - |
| Investing Cash Flow | - | - | - | ($15.0K) | - | - | - | $149.05M | - | - |
| Financing Cash Flow | - | - | - | $1.77M | - | - | - | ($149.10M) | - | - |
| CapEx | - | - | - | $15.0K | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | ($490.0K) | - | - | - | - | - | - |
Ratios
| Metric | Q1 '25 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | 54.7% | 52.6% | 41.4% | - | - | - | - | - | - |
| Operating margin | - | -14.4% | 10.4% | -12.7% | - | - | - | - | - | - |
| EBITDA margin | - | -14.0% | 10.8% | -12.1% | - | - | - | - | - | - |
| Net margin | - | -19.6% | -1.3% | -4.7% | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | -3.8% | - | - | - | - | - | - |
| FCF / Net income | - | - | - | 0.80 | - | - | - | - | - | - |
| R&D / Revenue | - | 8.7% | 10.5% | 12.6% | - | - | - | - | - | - |
| SG&A / Revenue | - | 43.1% | 31.7% | 44.7% | - | - | - | - | - | - |
| Effective tax rate | - | - | - | 663.3% | - | - | - | - | - | - |
| Return on assets | - | -11.7% | -0.6% | -1.6% | - | 0.9% | 0.3% | -0.6% | - | 0.6% |
| Return on equity | - | 9.8% | 0.7% | 1.8% | - | -4.7% | -1.4% | 3.8% | - | 7671.9% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 0.49 | 0.51 | 0.60 | 0.61 | 0.00 | 0.02 | 0.03 | 0.13 | 1.09 | 4.43 |
| Quick ratio | 0.33 | 0.34 | 0.41 | 0.42 | 0.00 | 0.02 | 0.03 | -2.24 | 1.09 | 4.43 |
| Cash ratio | 0.05 | 0.02 | 0.04 | 0.06 | 0.00 | 0.01 | 0.00 | 1.55 | 0.44 | 1.65 |
| Leverage | ||||||||||
| Debt / Equity | -0.06 | - | - | - | - | - | - | - | - | - |
| Debt / Assets | 0.09 | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | -14.8x | 72.6x | -13.8x | - | - | - | - | - | - |
| Equity multiplier | -0.72 | -0.84 | -1.11 | -1.12 | -4.91 | -5.18 | -5.76 | -6.23 | -27.21 | 13676.01 |
| Liabilities / Assets | 2.39 | 2.19 | 1.90 | 1.89 | 0.20 | 0.19 | 0.18 | 0.16 | 0.04 | 0.04 |
| Efficiency | ||||||||||
| Asset turnover | - | 0.60 | 0.48 | 0.34 | - | - | - | - | - | - |
| Inventory turnover | - | 1.08 | 0.90 | 0.83 | - | - | - | - | - | - |
| Days sales outstanding | - | 74d | 128d | 159d | - | - | - | - | - | - |
| Days inventory outstanding | - | 337d | 407d | 437d | - | - | - | - | - | - |
| Days payable outstanding | - | 167d | 222d | 261d | - | - | - | - | - | - |
| Cash conversion cycle | - | 244d | 313d | 336d | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | -472.9% | - | -6.6% | - | -118.5% | -332.5% | -94.6% | - | - |
| Net income growth (YoY) | - | - | - | -69.9% | - | -54.8% | -87.4% | - | - | - |
| EPS growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -9.2% | -241.1% | -228.4% | -257.0% | -56.7% | - | -43.0% | -15.2% | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-03-31.
Business segments
$62.86M totalAll Other Segments$62.86M · 100.0%
Product / service
$62.86M totalDevices$49.72M · 79.1%
Service$12.04M · 19.1%
Other$1.11M · 1.8%
Geographic
$62.86M totalEMEA$36.64M · 58.3%
Americas$16.88M · 26.8%
Asia Pacific$9.35M · 14.9%
Peer comparison
Same SIC group: Surgical & Medical Instruments & Apparatus
Comparing Aurora Technology Acquisition Corp. against the 5 most active filers in the same SIC group.